microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer
Prostate cancer is the most common cancer among men in the western world. Clinical practice is continuously challenged by the pitfalls of the available diagnostic tools. microRNAs may represent promising biomarkers in many types of human cancers, including prostate cancer. The aim of this study was...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-05-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428318775864 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850092562971361280 |
|---|---|
| author | Ahmed Hussein Zedan Torben Frøstrup Hansen Jannie Assenholt Mindaugas Pleckaitis Jonna Skov Madsen Palle Jörn Sloth Osther |
| author_facet | Ahmed Hussein Zedan Torben Frøstrup Hansen Jannie Assenholt Mindaugas Pleckaitis Jonna Skov Madsen Palle Jörn Sloth Osther |
| author_sort | Ahmed Hussein Zedan |
| collection | DOAJ |
| description | Prostate cancer is the most common cancer among men in the western world. Clinical practice is continuously challenged by the pitfalls of the available diagnostic tools. microRNAs may represent promising biomarkers in many types of human cancers, including prostate cancer. The aim of this study was to investigate microRNA expression in tumour tissue and matched plasma in a cohort of patients with primary metastatic prostate cancer. The relative expression of 12 microRNAs was assessed in diagnostic needle biopsies from the prostate and matched plasma samples in two prospective cohorts (screening cohorts) comprising 21 patients with metastatic prostate cancer and 25 control patients. An independent validation cohort of plasma samples was collected prospectively from 149 newly diagnosed patients with local/locally advanced prostate cancer. Analyses were performed using real-time polymerase chain reaction. miRNA-93 showed a significant negative correlation between expression in tumour tissue and plasma in patients with metastatic prostate cancer. Furthermore, the plasma level of miRNA-93 significantly decreased after treatment in patients with local/locally advanced prostate cancer compared to baseline plasma level. The expression of six microRNAs (let-7b, miRNA-34a, -125b, -143, -145 and -221) was downregulated, and three microRNAs (miRNA-21, -25 and miRNA-93) were upregulated in tumour tissue compared to benign prostate tissue. In plasma, six microRNAs were upregulated (miRNA-21, -125b, -126, -141, -143 and -375), while let-7b was downregulated in patients with metastatic prostate cancer compared to the control cohort. In the metastatic prostate cancer cohort, the expression of four microRNAs (miRNA-125b, -126, -143 and -221), and miRNA-141 in tissue was associated with Gleason score and prostate-specific antigen, respectively. The expression of miRNA-93 in tumour tissue was correlated with matched plasma levels and showed a significant decrease in plasma level after intervention in local prostate cancer. Differential expression between tumour and benign prostate was detected for several microRNAs in both tissue and plasma. |
| format | Article |
| id | doaj-art-25e1c63eb4d0472286e956f7de14e8d0 |
| institution | DOAJ |
| issn | 1423-0380 |
| language | English |
| publishDate | 2018-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Tumor Biology |
| spelling | doaj-art-25e1c63eb4d0472286e956f7de14e8d02025-08-20T02:42:07ZengSAGE PublishingTumor Biology1423-03802018-05-014010.1177/1010428318775864microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancerAhmed Hussein Zedan0Torben Frøstrup Hansen1Jannie Assenholt2Mindaugas Pleckaitis3Jonna Skov Madsen4Palle Jörn Sloth Osther5Institute of Regional Health Research, University of Southern Denmark, Odense, DenmarkInstitute of Regional Health Research, University of Southern Denmark, Odense, DenmarkDepartment of Biochemistry and Immunology, Vejle Hospital, Vejle, DenmarkDepartment of Clinical Pathology, Vejle Hospital, Vejle, DenmarkDepartment of Biochemistry and Immunology, Vejle Hospital, Vejle, DenmarkInstitute of Regional Health Research, University of Southern Denmark, Odense, DenmarkProstate cancer is the most common cancer among men in the western world. Clinical practice is continuously challenged by the pitfalls of the available diagnostic tools. microRNAs may represent promising biomarkers in many types of human cancers, including prostate cancer. The aim of this study was to investigate microRNA expression in tumour tissue and matched plasma in a cohort of patients with primary metastatic prostate cancer. The relative expression of 12 microRNAs was assessed in diagnostic needle biopsies from the prostate and matched plasma samples in two prospective cohorts (screening cohorts) comprising 21 patients with metastatic prostate cancer and 25 control patients. An independent validation cohort of plasma samples was collected prospectively from 149 newly diagnosed patients with local/locally advanced prostate cancer. Analyses were performed using real-time polymerase chain reaction. miRNA-93 showed a significant negative correlation between expression in tumour tissue and plasma in patients with metastatic prostate cancer. Furthermore, the plasma level of miRNA-93 significantly decreased after treatment in patients with local/locally advanced prostate cancer compared to baseline plasma level. The expression of six microRNAs (let-7b, miRNA-34a, -125b, -143, -145 and -221) was downregulated, and three microRNAs (miRNA-21, -25 and miRNA-93) were upregulated in tumour tissue compared to benign prostate tissue. In plasma, six microRNAs were upregulated (miRNA-21, -125b, -126, -141, -143 and -375), while let-7b was downregulated in patients with metastatic prostate cancer compared to the control cohort. In the metastatic prostate cancer cohort, the expression of four microRNAs (miRNA-125b, -126, -143 and -221), and miRNA-141 in tissue was associated with Gleason score and prostate-specific antigen, respectively. The expression of miRNA-93 in tumour tissue was correlated with matched plasma levels and showed a significant decrease in plasma level after intervention in local prostate cancer. Differential expression between tumour and benign prostate was detected for several microRNAs in both tissue and plasma.https://doi.org/10.1177/1010428318775864 |
| spellingShingle | Ahmed Hussein Zedan Torben Frøstrup Hansen Jannie Assenholt Mindaugas Pleckaitis Jonna Skov Madsen Palle Jörn Sloth Osther microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer Tumor Biology |
| title | microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer |
| title_full | microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer |
| title_fullStr | microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer |
| title_full_unstemmed | microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer |
| title_short | microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer |
| title_sort | microrna expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer |
| url | https://doi.org/10.1177/1010428318775864 |
| work_keys_str_mv | AT ahmedhusseinzedan micrornaexpressionintumourtissueandplasmainpatientswithnewlydiagnosedmetastaticprostatecancer AT torbenfrøstruphansen micrornaexpressionintumourtissueandplasmainpatientswithnewlydiagnosedmetastaticprostatecancer AT jannieassenholt micrornaexpressionintumourtissueandplasmainpatientswithnewlydiagnosedmetastaticprostatecancer AT mindaugaspleckaitis micrornaexpressionintumourtissueandplasmainpatientswithnewlydiagnosedmetastaticprostatecancer AT jonnaskovmadsen micrornaexpressionintumourtissueandplasmainpatientswithnewlydiagnosedmetastaticprostatecancer AT pallejornslothosther micrornaexpressionintumourtissueandplasmainpatientswithnewlydiagnosedmetastaticprostatecancer |